Remplissage Versus Latarjet Coracoid Transfer for Recurrent Shoulder Instability — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Remplissage Versus Latarjet Coracoid Transfer for Recurrent Shoulder Instability — Stella

Recruiting

Back to Shoulder Dislocation trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Canada

Pan Am Clinic, Winnipeg, Manitoba

Fowler Kennedy Sport Medicine Clinic, London, Ontario

Key details

Sponsor

Western University, Canada

Collaborators

Panam Clinic

Enrollment target

~30 participants

Started

October 2018

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

15 Years – 60 Years

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov